Overview


Injectable Drug Delivery Formulation Market Introduction
Injectable Drug Delivery Formulation Market is forecasted to value over USD xx billion by 2027 end and register a CAGR of xx% from the forecast period 2020-2027.
FutureWise Market Research has illustrated a report that provides an in-depth anatomy of the trends affecting its growth. Moreover, it includes intricate insights on profitability graph, market share, SWOT analysis and geographical augmentation of this business. Furthermore, the report provides information on the status of key market players in the competitive landscape analysis of this market.
The Injectable Drug Delivery Formulation Market is projected to achieve significant growth by the end of the forecast period as per the research study conducted by FutureWise research analysts. The report explains that this business is predicted to record a remarkable growth rate over the forecast period. This report provides important information regarding the total valuation that this industry holds presently and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
• Becton, Dickinson and Company (U.S.)
• Baxter International Inc. (U.S.))
• Gerresheimer AG (Germany)
• Schott AG (Germany)
• Sandoz (Germany)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Eli Lilly and Company (U.S.)
(Note: The list of the major players will be updated with the latest market scenario and trends)
Injectable Drug Delivery Formulation Market
By Product Type
• Conventional Drug Delivery Formulations
• Novel Drug Delivery Formulations
• Long-acting Formulations
By Application
• Autoimmune Diseases
• Hormonal Disorders
• Oncology
• Orphan Diseases
• Others
By Region
• North America
Europe
• Asia-Pacific
• Rest of the world
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth
• To provide with an exhaustive analysis on the Injectable Drug Delivery Formulation Market by product type, by application and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific and rest of the world
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization services offered are free of charge with purchase of any license of the report.
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data From Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Injectable Drug Delivery Formulation Market Variables, Trends
    • Scope
        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards And Compliances
  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Injectable Drug Delivery Formulation Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Injectable Drug Delivery Formulation Market, By Product Type Historical Analysis and Forecast 2020-2027 (USD Million)
    •   1. Conventional Drug Delivery Formulations
        2. Novel Drug Delivery Formulations
        3. Long-acting Formulations
  • 8.   Global Injectable Drug Delivery Formulation Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million)
    •   1. Autoimmune Diseases
        2. Hormonal Disorders
        3. Oncology
        4. Orphan Diseases
        5. Others
  • 9.   North America Injectable Drug Delivery Formulation Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) along with expected regulatory needs
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
           2.1. U.S.A
         2.2. Canada
        3. Market Size (USD Million) Forecast for North America 2020-2027
  • 10.   Europe Injectable Drug Delivery Formulation Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         2.1. Germany
          2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Switzerland
         2.9.Rest of Western Europe
  • 11.   Asia Pacific Injectable Drug Delivery Formulation Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) - along
    • with expected regulatory needs
        1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         2.1. Japan
         2.2. China
         2.3. Singapore
         2.4. India
         2.5. Australia and New Zealand
         2.6. ASEAN
         2.7. South Korea
         2.8. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
  • 12.   Rest of the World Injectable Drug Delivery Formulation Market Analysis 2015–2019 and Forecast
    • 2020–2027 (USD Million) along with expected regulatory needs
        1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2020-2027
  • 13.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
    •     1. Becton, Dickinson and Company (U.S.)
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
           2. Baxter International Inc. (U.S.))
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Gerresheimer AG (Germany)
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Schott AG (Germany)
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Sandoz (Germany)
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
         6. Teva Pharmaceutical Industries Ltd. (Israel)
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
          7. Eli Lilly and Company (U.S.)
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
  • 14.   FutureWise SME key takeaway points for Client
Partner

Our Clients